HONIG will be one of the main partners contributing to the clinical research carried out in WP3 for
the studies related to hemodynamic changes on VAD (in the perspective to monitor/help recovery
and patient-device adaptation), and in the early recognition of VAD-related problems. Furthermore
HONIG will contribute to the specialists specifications during the development of patients and
clinicians oriented systems expected to be delivered in WP7 WP8 and WP9 to the clinical test
validation in WP11, to project dissemination in WP2.